Clinical Trials Browser

Phase EARLY_PHASE1 × larotrectinib × 90 days × Clear all

NCT04655404 2026-03-18

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Phase EARLY_PHASE1 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma